© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Formulary
FDA Update: Report Claims “Power Grab,” Dems Say Hahn Blocked From Testifying
September 20, 2020
Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.
The Challenges of Treating Primary Progressive MS
September 13, 2020
A session at MSVirtual2020 covers the difficulty of finding treatments for some forms of MS.
5 Takeaways From the European Society of Cardiology 2020 Congress
September 02, 2020
The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.
Electronic Prior Authorization is Catching on
August 27, 2020
But there are plenty of holdouts. Half of submissions are still done by phone or fax.
ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1
August 08, 2020
Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.
An Update for Cardiologists Who See Patients With Type 2 Diabetes
August 05, 2020
The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.
5 Tips for Employers on Reforming and Optimizing Medication Use
August 04, 2020
Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.
Is the Biosimilars Waiting Game Finally Over?
July 30, 2020
Advocates say a number of regulatory changes could help bring more of these products on to the market.
Heart Drug Updates: Fast Track for Farxiga after MI, Brilinta Plus Aspirin After Stroke or TIA, NDA for Vericiguat
July 18, 2020
Heart disease drugs were in the news this week.